Fingolimod

Back to search

Molecule Structure

Scientific Name

Fingolimod

Description of the Drug

Fingolimod is a sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08868

Brand Name(s)

Gilenya

Company Owner(s)

Teva Pharmaceuticals Usa Inc, Alkem Laboratories Ltd, Apotex Inc, Hec Pharm Co Ltd, Sun Pharmaceutical Industries Ltd, Biocon Ltd, Accord Healthcare Inc, Glenmark Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Hetero Labs Ltd Unit V

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sphingosine 1-phosphate receptor PROTEIN FAMILY BINDING AGENT CHEMBL2363041
Sphingosine 1-phosphate receptor PROTEIN FAMILY AGONIST CHEMBL2363041

Unichem Links

SureChEMBL SCHEMBL7445
Human Metabolome Database HMDB0252262
DrugBank DB08868
PubChem: Thomson Pharma 14800795
PubChem 107970
NMRShiftDB 70114025
LINCS LSM-45416
Nikkaji J729.665G
BindingDB 50158336
EPA CompTox Dashboard DTXSID40167363
DrugCentral 4167
Brenda 213385 2251 212352 38999
ChemicalBook CB92498299
Guide to Pharmacology 2407
rxnorm FINGOLIMOD GILENYA FINGOLIMOD HYDROCHLORIDE
ChEBI 63115
ZINC ZINC000001542002